Foundayo 0.8 mg Tablets – 30s

FOUNDAYO 0.8 mg Tablets – 30s (Orforglipron)

Once-Daily Oral GLP-1 Treatment for Weight Management

FOUNDAYO 0.8 mg contains orforglipron, an oral GLP-1 receptor agonist used for chronic weight management in eligible adults with obesity or overweight with weight-related health conditions. It is intended to be used alongside a reduced-calorie diet and increased physical activity.

Why Choose FOUNDAYO 0.8 mg?

✔ Oral GLP-1 Medicine – Convenient tablet formulation without the need for injections.
✔ Supports Weight Management – Helps regulate appetite and may reduce food intake.
✔ Starting Strength – 0.8 mg is used as the initial dose when beginning treatment as prescribed.
✔ Once-Daily Dosing – Designed for convenient daily administration.
✔ 30-Tablet Pack – Convenient supply for prescribed daily use.

Active Ingredient:

● Orforglipron 0.8 mg – An oral GLP-1 receptor agonist that helps regulate appetite and supports medically supervised weight management.

How to Use:

Take FOUNDAYO 0.8 mg once daily or exactly as directed by your doctor. Treatment generally begins with the 0.8 mg strength before gradual dose increases according to the prescribed dosing schedule. Do not change your dose without medical advice.

✅ For Medically Supervised Weight Management

FOUNDAYO is designed to complement a reduced-calorie diet and increased physical activity as part of a comprehensive weight-management program.

⚠️ Important: FOUNDAYO is a prescription medicine and should only be used under the supervision of a healthcare professional. Common side effects may include nausea, diarrhea, constipation, vomiting, indigestion and abdominal discomfort.

🛒 Available from PharmaCare – Online Pharmacy Qatar.